首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry
【24h】

A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry

机译:超高效液相色谱-三重四极杆质谱法测定脱落尿路上皮细胞中马兜铃酸衍生的DNA加合物的新方法

获取原文
获取原文并翻译 | 示例
       

摘要

Aristolochic acid nephropathy (AAN) is associated with the prolonged exposure to nephrotoxic and carcinogenic aristolochic acids (AAs). DNA adducts induced by AAs have been proven to be critical biomarkers for AAN. Therefore, accurate and specific quantification of AA-DNA adducts is important. In this study, a specific method using ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed and applied for the determination of 7-(deoxyadenosin-N6-yl)aristolactam I (dA-AAI) in exfoliated urothelial cells of AA-dosed rats. After the isolation from urine samples, DNA in urothelial cells were subjected to enzymatic digestion and solid-phase extraction on a C18 Sep-Pak cartridge for the enrichment of DNA adducts. The sample extracts were analyzed by reverse-phase UPLC-MS/MS with electrospray ionization in positive ion mode. The quantification of the AA-DNA adduct was performed by using multiple reaction monitoring with reserpine as internal standard. The method provided good accuracy and precision with a detection limit of 1ng/ml, which allowed the detection of trace of dA-AAI in exfoliated urothelial cells. After one-month oral dose of AAI at 10mg/kg/day, 2.1±0.3 dA-AAI per 10~9 normal dA was detected in exfoliated urothelial cells of rats. Compared to the traditional methods such as ~(32)P-postlabelling and HPLC with fluorescence detection, the developed UPLC-MS/MS method is more specific and rapid with a retention time of 4min. The outcome of this study may have clinical significance for diagnosing and monitoring AA-associated disease because detection of DNA adducts in exfoliated urothelial cells is non-invasive and convenient.
机译:马兜铃酸肾病(AAN)与长时间暴露于肾毒性和致癌性马兜铃酸(AAs)有关。由AA诱导的DNA加合物已被证明是AAN的关键生物标志物。因此,AA-DNA加合物的准确和特异性定量非常重要。在这项研究中,开发了一种使用超高效液相色谱-串联质谱(UPLC-MS / MS)的特定方法,并将其用于测定脱落的尿路上皮中的7-(脱氧腺苷-N6-基)马兜铃内酰胺I(dA-AAI)。 AA给药的大鼠细胞。从尿液样本中分离后,尿路上皮细胞中的DNA在C18 Sep-Pak柱上进行酶消化和固相萃取,以富集DNA加合物。样品提取物通过反相UPLC-MS / MS在正离子模式下进行电喷雾电离分析。通过使用以利血平为内标的多反应监测,对AA-DNA加合物进行定量。该方法提供了良好的准确性和精密度,检测限为1ng / ml,可检测到脱落的尿路上皮细胞中的dA-AAI痕迹。以10mg / kg /天的剂量口服AAI 1个月后,在大鼠脱落的尿路上皮细胞中每10〜9正常dA检测到2.1±0.3 dA-AAI。与〜(32)P后标记和采用荧光检测的HPLC等传统方法相比,开发的UPLC-MS / MS方法具有更高的特异性和快速性,保留时间为4分钟。这项研究的结果可能对诊断和监测与AA相关的疾病具有临床意义,因为在脱落的尿道上皮细胞中检测DNA加合物是非侵入性且方便的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号